Piramal Pharma Ltd. (PPLPHARMA)
Market Closed
16 Jun, 22:00
MSE XNSE Primary MSE ₹
166. 00
-1.25
-0.7474%
₹
- Market Cap
- P/E Ratio
- Div Yield
46,462 Volume
0 Eps
₹ 167.25
Previous Close Want to track PPLPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.84 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 1.08 | 1.16 |
| | | - | 0.03 |
| | | - | 0.17 |
| | | - | - |
| | | - | 0.34 |
| | | - | 0.04 |
PPLPHARMA Earnings Reports FAQ
What is the earnings per share (EPS) for PPLPHARMA?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 2,800%, reflecting the PPLPHARMA's performance and MSE market conditions.
When is the next earnings release date?
Piramal Pharma Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Piramal Pharma Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PPLPHARMA at this time, as Piramal Pharma Ltd has no recent EPS data to calculate it.
